-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
-
Summary
-
BriaCell Therapeutics Corp. quarterly Comprehensive Income (Loss), Net of Tax, Attributable to Parent history and growth rate from Q4 2021 to Q1 2023.
- BriaCell Therapeutics Corp. Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the quarter ending April 30, 2023 was -$4.9M, a 51.1% increase year-over-year.
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Quarterly (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, YoY Quarterly Growth (%)